Understanding factors that affect the severity and survival of sickle cell disease
Official title: 'Omics predictors of Sickle Cell Severity and Survival
Funded at Duke University · NIH-10983638 · Data updated 2026-11-12
This study is looking at how different biological factors affect the health and survival of people with sickle cell disease, especially those over 50, to help create better, personalized treatments for them.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $430,956 |
| NIH project number | 1R21AG084916-01A1 |
| Project ID | NIH-10983638 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 50 and older who have been diagnosed with sickle cell disease.
✕Less likely to help
Patients with sickle cell disease who are under the age of 50 may not receive direct benefits from this research.
What this research studies
This research investigates how various biological factors influence the severity of sickle cell disease (SCD) and the survival of patients, particularly those over the age of 50. By analyzing multi-omics data, which includes genetic, biochemical, and clinical information, the study aims to identify predictors of health outcomes in SCD patients. The goal is to enhance personalized care and treatment strategies for individuals living with this condition, especially as they age. The research will utilize data from a long-term follow-up of patients to better understand the relationship between these biological markers and patient health.
Why it matters
Potential benefit: If successful, this research could lead to improved care strategies and potentially extend the life expectancy of patients with sickle cell disease.
How similar studies have gone: Previous research has shown promising results in using multi-omics approaches to understand complex diseases, suggesting that this method could be effective for sickle cell disease as well.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Ashley-Koch, Allison E — Duke University
- Study coordinator: Ashley-Koch, Allison E
Related research
Other NIH-funded projects on the same topics.
-
Investigating genetic factors in Lewy body diseases
This study is looking at how changes in a specific gene might play a role in conditions like Parkinson's disease and dementia, so that people can better understand how their genetics affect their health and possibly find more tailored treatments.
-
Targeting the PAX3-FOXO1 protein in a deadly childhood cancer
This study is looking at a specific protein that helps a tough childhood cancer called alveolar rhabdomyosarcoma, with the goal of finding new ways to treat kids who have this illness.
-
Improving population health by studying reproduction and development
This study is looking at how different things in our environment can impact pregnancy and the health of babies, and it’s for people who are planning to have children or are already parents, as it aims to help improve understanding and outcomes for everyone involved.
-
Modeling axon degeneration in C. elegans to help ALS patients
Researchers are using a tiny worm model to uncover how axons break down, which could point to new ways to help people with ALS and related nerve diseases.
-
Induced Suppression of Platelet Activity in Aneurysmal SAH Management
A new approach tests whether carefully reducing platelet activity can improve outcomes after aneurysmal subarachnoid hemorrhage.
-
AI-enhanced virtual reality tool to support remote emergency brain surgery training in Tanzania
A new AI-powered virtual reality tool helps non-experts in low-resource areas get real-time remote guidance for emergency traumatic brain injury surgery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.